Use of cyp2d6 inhibitors in combination therapies

Details Use of cyp2d6 inhibitors in combination therapies Use of cyp2d6 inhibitors in combination therapies

A - Human Necessities

61

K

A61K 31/506 (2006.01) A61K 31/445 (2006.01) A61K 31/4709 (2006.01) A61K 31/475 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2367052

This invention relates to the use of a CYP2D6 inhibitor in combination with a drug having CYP2D6 catalyzed metabolism, wherein the drug and the CYP2D6 inhibitor are not the same compound; and pharmaceutical compositions for said use.

L'invention concerne l'utilisation d'un inhibiteur CYP2D6 en combinaison avec un médicament ayant un métabolisme catalysé CYP2D6, le médicament et l'inhibiteur CYP2D6 étant des composés différents. L'invention concerne également des compositions pharmaceutiques pour cette utilisation.

Affiliated with

Also associated with

Rating

Use of cyp2d6 inhibitors in combination therapies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of cyp2d6 inhibitors in combination therapies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cyp2d6 inhibitors in combination therapies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2057135